Found: 6
Select item for more details and to access through your institution.
Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023.
- Published in:
- HIV Medicine, 2023, v. 24, n. 11, p. 1126, doi. 10.1111/hiv.13542
- By:
- Publication type:
- Article
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021.
- Published in:
- HIV Medicine, 2022, v. 23, n. 8, p. 849, doi. 10.1111/hiv.13268
- By:
- Publication type:
- Article
Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 9, p. 1312, doi. 10.1093/cid/ciad346
- By:
- Publication type:
- Article
First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 6, p. 875, doi. 10.1093/cid/ciad267
- By:
- Publication type:
- Article
Hiv-behandeling anno 2019: stand van zaken.
- Published in:
- Nederlands Platform voor Farmaceutisch Onderzoek, 2019, v. 4, p. 1
- By:
- Publication type:
- Article
Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 10, p. 1445, doi. 10.1007/s40262-023-01289-5
- By:
- Publication type:
- Article